Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 23.81% is in line with its 3-year average of 22.57%, around the middle of its 3-year range (5.33%–43.28%).
93.98% above its 12-month average of 12.27%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-03-31): 9.80%.
GROSS MARGIN
23.81%
GROSS MARGIN AVG TTM
12.27%
GROSS MARGIN AVG 3Y
19.12%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+93.98%
CURRENT VS 3Y AVG
+24.53%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-42.22%
vs the sector median at left
WORK Medical Technology Group Ltd. Class A
Market Cap
$3.63M
Gross Margin
23.81%
TTM Avg
12.27%
3Y Avg
19.12%
5Y Avg
N/A
Market Cap
$3.65M
Gross Margin
0.00%
TTM Avg
41.76%
3Y Avg
-40.89%
5Y Avg
-27.26%
Market Cap
$3.53M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.90M
Gross Margin
19.42%
TTM Avg
29.47%
3Y Avg
-30.48%
5Y Avg
-4.58%
Market Cap
$3.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
-19.05%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| WORK Medical Technology Group Ltd. Class A (WOK) | $3.63M | 23.81% | 12.27% | 19.12% | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 0.00% | 41.76% | -40.89% | -27.26% |
| Evogene Ltd. (EVGN)vs › | $3.65M | -6.25% | 25.54% | 36.71% | 34.86% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.50M | 34.17% | 21.29% | 6.69% | 5.35% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | 19.42% | 29.47% | -30.48% | -4.58% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 0.00% | 0.00% | 25.00% | -19.05% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 79.65% | 78.98% | 76.82% | 80.07% |
Gross Margin
23.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 9.80% |
| 2025-09-30 | 14.75% |
| 2025-03-29 | 34.38% |
| 2024-09-29 | 21.39% |
| 2024-03-29 | 29.06% |
| 2023-09-29 | 5.33% |
| 2023-03-29 | 43.28% |
